Donegan Michael C

Prin. Fin. and Acctg. OfficerTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Jan 30, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2023Sell(S)49$5.09$24912K
Jan 26, 2023Option exercise(M)2K$010K
Jan 26, 2023Sell(S)2K$5.08$8K12K
Jan 26, 2023Option exercise(M)1K$014K
Jan 26, 2023Option exercise(M)2K$012K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2023Option exercise(M)2K$00
Jan 26, 2023Option exercise(M)1K$00
Jan 26, 2023Option exercise(M)2K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-005554) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.